Yangzhou, China

Kun Qian

This inventor holds 1 USPTO granted patent. Top assignee: Yangzhou University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kun Qian. Retrieved from https://idiyas.com/inventor/kun-qian-70tcxqay

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kun Qian: Innovator in Recombinant Herpesvirus Research

Introduction

Kun Qian is a prominent inventor based in Yangzhou, China. He has made significant contributions to the field of virology, particularly in the development of recombinant herpesvirus technologies. His work is instrumental in advancing research and applications in this area.

Latest Patents

Kun Qian holds a patent for a "Recombinant Herpesvirus of Turkeys (HVT) and Preparation Method and Use Thereof." This innovative patent reflects his expertise and dedication to improving viral research methodologies.

Career Highlights

Kun Qian is affiliated with Yangzhou University, where he engages in cutting-edge research and development. His academic background and professional experience have positioned him as a key figure in his field.

Collaborations

He collaborates with notable colleagues, including Jianqiang Ye and Bin Shi, to further enhance the impact of his research. Their combined efforts contribute to the advancement of knowledge in virology.

Conclusion

Kun Qian's work exemplifies the importance of innovation in scientific research. His contributions to recombinant herpesvirus technology are paving the way for future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…